Could antibody infusions replace daily HIV pills?
NCT ID NCT03526848
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 28 times
Summary
This study tested whether infusions of two lab-made antibodies (3BNC117 and 10-1074) can safely control HIV in people who temporarily stop their daily antiretroviral therapy (ART). Twenty-six adults with well-controlled HIV received seven antibody infusions and were monitored for viral rebound. The goal was to see if the antibodies could keep the virus suppressed and reduce the hidden HIV reservoir, potentially allowing for treatment-free periods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ragon Institute of MGH, MIT, and Harvard
Boston, Massachusetts, 02114, United States
-
The Rockefeller University
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.